Abstract:Abstract A key hallmark of Parkinson’s disease (PD) is Lewy pathology. Composed of α-synuclein, Lewy pathology is found both in dopaminergic neurons that modulate motor function, and cortical regions that control cognitive function. Recent work has established the molecular identity of dopaminergic neurons susceptible to death, but little is known about cortical neurons susceptible to Lewy pathology or molecular changes induced by aggregates. In the current study, we use spatial transcriptomics to capture whole transcriptome signatures from cortical neurons with α-synuclein pathology compared to neurons without pathology. We find, both in PD and related PD dementia, dementia with Lewy bodies and in the pre-formed fibril α-synucleinopathy mouse model, that specific classes of excitatory neurons are vulnerable to developing Lewy pathology. Further, we identify conserved gene expression changes in aggregate-bearing neurons that we designate the Lewy-associated molecular dysfunction from aggregates (LAMDA) signature. Neurons with aggregates downregulate synaptic, mitochondrial, ubiquitin-proteasome, endo-lysosomal, and cytoskeletal genes and upregulate DNA repair and complement/cytokine genes. Our results identify neurons vulnerable to Lewy pathology in the PD cortex and describe a conserved signature of molecular dysfunction in both mice and humans.

What problem does this paper attempt to address?

This paper aims to address the molecular dysfunction related to Lewy pathology in Parkinson's disease (PD). Specifically, the researchers used spatial transcriptomics technology to capture the whole - transcriptome characteristics of cortical neurons containing α - synuclein pathology and compared them with neurons without pathology. Through this method, they hope to discover which neurons are prone to form Lewy pathology and how the molecular processes in these neurons have changed. ### Research Background A key hallmark of Parkinson's disease is Lewy pathology, which is mainly composed of α - synuclein and appears not only in dopaminergic neurons that regulate motor function but also in cortical areas that control cognitive function. Although recent studies have identified the molecular identity of dopaminergic neurons vulnerable to death, little is known about cortical neurons vulnerable to Lewy pathology and their molecular changes. ### Research Objectives 1. **Identify cortical neurons vulnerable to Lewy pathology**: Through spatial transcriptomics technology, the researchers hope to determine which types of cortical neurons are prone to form Lewy pathology. 2. **Analyze molecular changes in these neurons**: By comparing the gene expression differences between neurons with α - synuclein pathology and normal neurons, reveal the impact of Lewy pathology on neuronal function. ### Research Methods - **Sample selection**: The researchers selected brain samples from 8 patients diagnosed with Parkinson's disease (PD), Parkinson's disease dementia (PDD), or dementia with Lewy bodies (DLB), as well as mouse models injected with α - synuclein pre - formed fibrils (PFF). - **Spatial transcriptomics**: Using GeoMx Digital Spatial Profiler (DSP) technology, perform whole - transcriptome analysis on neurons with α - synuclein pathology and normal neurons. - **Data analysis**: Through differential gene expression analysis (DEG) and gene set enrichment analysis (GSEA), identify genes that are significantly up - regulated and down - regulated in neurons with Lewy pathology and their related biological pathways. ### Main Findings - **Neuron types vulnerable to Lewy pathology**: The study found that specific types of excitatory neurons (such as projection neurons in layer 5 and neurons in layer 6b) are particularly prone to form Lewy pathology. - **Molecular dysfunction**: Neurons containing Lewy pathology exhibit extensive cellular dysfunction, including down - regulation of synaptic, mitochondrial, ubiquitin - proteasome, endocytic - lysosomal and cytoskeletal - related genes, and up - regulation of DNA repair, apoptosis and complement / cytokine - related genes. - **Conserved molecular features**: In mouse models and human samples, the researchers discovered a set of conserved gene expression changes, known as the Lewy - associated molecular dysfunction (LAMDA) signature. This indicates that Lewy pathology has similar molecular mechanisms in different species. ### Conclusion This study reveals the types of neurons in the Parkinson's disease cortex that are vulnerable to Lewy pathology and describes the conserved molecular dysfunction characteristics in these neurons. These findings provide important clues for understanding the molecular mechanisms of Lewy pathology and may provide new targets for future treatment strategies.

Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology

Cortical synaptic vulnerabilities revealed in a α-synuclein aggregation model of Parkinson′s disease

Imaging spatial transcriptomics reveals molecular patterns of vulnerability to pathology in a transgenic α-synucleinopathy model

The spatial landscape of glial pathology and T-cell response in Parkinson’s disease substantia nigra

Cortico-amygdala synaptic structural abnormalities produced by templated aggregation of α-synuclein

Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson's disease

Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of Neuroinflammation

Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson's disease

Single-cell transcriptomic and proteomic analysis of Parkinson's disease brains

A stem cell-based assay platform demonstrates alpha-synuclein dependent synaptic dysfunction in patient-derived cortical neurons

Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer's disease

Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson's disease

Network Proteomics of the Lewy Body Dementia Brain Reveals Presynaptic Signatures Distinct from Alzheimer’s Disease

Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson’s disease patients

Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations

Author Correction: A Shared Disease-Associated Oligodendrocyte Signature among Multiple CNS Pathologies

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders

Excitatory synaptic structural abnormalities produced by templated aggregation of α-syn in the basolateral amygdala

Alpha-Synuclein Pre-Formed Fibrils Injected into Prefrontal Cortex Primarily Spread to Cortical and Subcortical Structures

Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and dementia with Lewy bodies

A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs